Tissue dyslipidemia in salmonella-infected rats treated with amoxillin and pefloxacin

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Rotimi, Solomon O ^a   Ojo, David A ^b   Talabi, Olusola A ^b   Balogun, Elizabeth A ^b   Ademuyiwa, Oladipo ^b  

^a Centre for Economic Policy and Development Research   (Nigeria)

^b FEDERAL UNIVERSITY OF AGRICULTURE   (Nigeria)

Author keywords

Amoxicillin; Cholesterogenesis; Pefloxacin; Phospholipidosis; Salmonellosis

Indexed keywords

AMOXICILLIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEFLOXACIN; PHOSPHOLIPID; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; BRAIN LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; ERYTHROCYTE; ERYTHROCYTE GHOST; ERYTHROCYTE LEVEL; FATTY ACID BLOOD LEVEL; FECES MICROFLORA; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPIDOSIS; LIVER LEVEL; MALE; MOUTH INFECTION; NONHUMAN; RAT; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CHOLESTEROL; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; LIPID METABOLISM; LIPIDS; MALE; PEFLOXACIN; PHOSPHOLIPIDS; RATS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; TISSUE DISTRIBUTION; TRIGLYCERIDES;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 84868562288     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-152     Document Type: Article

References (50)

1. Host-Salmonella interaction: human trials. Levine MM, Tacket CO, Sztein MB, Microbes Infect 2001 3 1271 1279 10.1016/S1286-4579(01)01487-3 11755415 (Pubitemid 34033762)
2. Antimicrobial drug resistance in Salmonella enterica. Parry CM, Curr Opin Infect Dis 2003 16 467 472 10.1097/00001432-200310000-00014 14502000 (Pubitemid 37267266)
3. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Darwin KH, Miller VL, Clin Microbiol Rev 1999 12 405 428 10398673 (Pubitemid 29330137)
4. Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells. Clark MA, Jepson MA, Simmons NL, Hirst BH, Res Microbiol 1994 145 543 552 10.1016/0923-2508(94)90031-0 7855440 (Pubitemid 24296198)
5. Neonatal sepsis due to Salmonella Typhi and Paratyphi A. Mohanty S, Gaind R, Sehgal R, Chellani H, Deb M, J Infect Dev Ctries 2009 3 633 638 19801808
6. Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Newcomb D, Bolgos G, Green L, Remick DG, Shock 1998 10 110 117 10.1097/00024382-199808000-00005 9721977 (Pubitemid 128463842)
7. Sepsis and multiple brain abscesses caused by Salmonella paratyphi B in an infant: successful treatment with sulbactam-ampicillin and surgical drainage. Yildiran A, Siga E, Baykal S, Okten A, Turk J Pediatr 2001 43 85 87 11297167 (Pubitemid 32167698)
8. Salmonella sepsis in ulcerative colitis: report of a case and review of the literature. Young DK, Reid KM, J Am Osteopath Assoc 1987 87 488 492 3112045 (Pubitemid 17101294)
9. Changing trends in newborn sepsis in Sagamu, Nigeria: bacterial aetiology, risk factors and antibiotic susceptibility. Ogunlesi TA, Ogunfowora OB, Osinupebi O, Olanrewaju DM, J Paediatr Child Health 2011 47 5 11 10.1111/j.1440-1754.2010.01882.x 20973858
10. Cellular energetic metabolism in sepsis: the need for a systems approach. Carre JE, Singer M, Biochim Biophys Acta 2008 1777 763 771 10.1016/j.bbabio. 2008.04.024 18482575
11. Cytokines and glucocorticoids in the regulation of the hepato-skeletal muscle axis in sepsis. Fischer JE, Hasselgren PO, Am J Surg 1991 161 266 271 10.1016/0002-9610(91)91143-7 1990881
12. Protein metabolism in different types of skeletal muscle during early and late sepsis in rats. Hasselgren PO, Talamini M, James JH, Fischer JE, Arch Surg 1986 121 918 923 10.1001/archsurg.1986.01400080064011 3729710 (Pubitemid 16039339)
13. Features of clinic, diagnostics and treatment of typhoid fever in young patients. Kovalenko AN, Zhdanov KV, Volzhanin VM, Shishkin MK, Tokmakov VS, Karpov AV, Murachev AA, Kondratenok VA, Voen Med Zh 2011 332 33 39 21506329
14. Efficacy of various antimicrobial agents in the treatment of epidemic typhoid fever. Makhnev MV, Antibiot Khimioter 2003 48 27 34 14558416
15. Typhoid fever in the United States and antibiotic choice. Basnyat B, JAMA 2010 303 34 author reply 34-35 20051567
16. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B, JAMA 1995 274 968 974 10.1001/jama.1995.03530120060042 7674528
17. A review of the disease burden, impact and prevention of typhoid fever in Nigeria. Iperepolu OH, Entonu PE, Agwale SM, West Afr J Med 2008 27 127 133 19256314
18. A rat model for dose-response relationships of Salmonella Enteritidis infection. Havelaar AH, Garssen J, Takumi K, Koedam MA, Dufrenne JB, van Leusden FM, de La Fonteyne L, Bousema JT, Vos JG, J Appl Microbiol 2001 91 442 452 10.1046/j.1365-2672.2001.01399.x 11556909 (Pubitemid 34205755)
19. A rat model of infection by Salmonella typhimurium or Salm. enteritidis. Naughton PJ, Grant G, Spencer RJ, Bardocz S, Pusztai A, J Appl Bacteriol 1996 81 651 656 8972092 (Pubitemid 26421178)
20. Acute-phase proteins and other systemic responses to inflammation. Gabay C, Kushner I, N Engl J Med 1999 340 448 454 10.1056/NEJM199902113400607 9971870 (Pubitemid 29084777)
21. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR, J Clin Endocrinol Metab 1992 74 1045 1052 10.1210/jc.74.5.1045 1373735
22. Changes in serum lipoprotein pattern induced by acute infections. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR, Metabolism 1988 37 859 865 10.1016/0026-0495(88)90120-5 3419323
23. Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice. Tiirola T, Jauhiainen M, Erkkila L, Bloigu A, Leinonen M, Haasio K, Laitinen K, Saikku P, Int J Antimicrob Agents 2007 29 741 742 10.1016/j.ijantimicag.2007.02.001 17369028 (Pubitemid 46722677)
24. Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo. Nonogaki K, Moser AH, Pan XM, Staprans I, Grunfeld C, Feingold KR, J Lipid Res 1995 36 1987 1995 8558086
25. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Memon RA, Grunfeld C, Moser AH, Feingold KR, Endocrinology 1993 132 2246 2253 10.1210/en.132.5.2246 8477669 (Pubitemid 23133278)
26. Effects of endotoxin and cytokines on lipid metabolism. Hardardottir I, Grunfeld C, Feingold KR, Curr Opin Lipidol 1994 5 207 215 10.1097/00041433- 199405030-00008 7952915 (Pubitemid 24198817)
27. LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Hardardottir I, Sipe J, Moser AH, Fielding CJ, Feingold KR, Grunfeld C, Biochim Biophys Acta 1997 1344 210 220 10.1016/S0005-2760(96)00143-9 9059511 (Pubitemid 27079787)
28. Endotoxin inhibits catabolism of low density lipoproteins in vivo: an experimental study in the rat. Xu N, Nilsson A, Scand J Clin Lab Invest 1996 56 53 61 10.3109/00365519609088588 8850173 (Pubitemid 26063568)
29. Changes in cellular and plasma membrane phospholipid composition after lipopolysaccharide stimulation of human neutrophils, studied by 31P NMR. Wright LC, Nouri-Sorkhabi MH, May GL, Danckwerts LS, Kuchel PW, Sorrell TC, Eur J Biochem 1997 243 328 335 10.1111/j.1432-1033.1997.0328a.x 9030756 (Pubitemid 27060419)
30. Alterations of lipid metabolism in mice injected with endotoxin. Sakaguchi O, Sakaguchi S, Microbiol Immunol 1979 23 71 85 379551 (Pubitemid 9160442)
31. Lead-induced phospholipidosis and cholesterogenesis in rat tissues. Ademuyiwa O, Agarwal R, Chandra R, Behari JR, Chem Biol Interact 2009 179 314 320 10.1016/j.cbi.2008.10.057 19056365
32. Tumor necrosis factor-alpha independent downregulation of hepatic cholesterol 7alpha hydroxylase gene in mice treated with lead nitrate. Kojima M, Sekikawa K, Nemoto K, Degawa M, Toxicol Sci 2005 87 2 537 542 10.1093/toxsci/kfi267 16049268 (Pubitemid 41300700)
33. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR, J Clin Invest 1999 103 907 914 10.1172/JCI5578 10079112 (Pubitemid 29152637)
34. Lipid transport and storage. Botham KM, Harper's Illustrated Biochemistry Boston: McGraw-Hill, Murray RK, Granner DK, Rodwell VW, 27 2006 217 229 23194092
35. The in vivo effect of lipopolysaccharide on the spontaneous release of transmitter from motor nerve terminals. Liu SH, Sheu TJ, Lin RH, Lin-Shiau SY, Br J Pharmacol 1995 116 1757 1760 10.1111/j.1476-5381.1995.tb16659.x 8528556
36. Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. Feingold KR, Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Atherosclerosis 1999 142 379 387 10.1016/S0021-9150(98)00265-2 10030389 (Pubitemid 29059496)
37. A toxicogenomic approach to drug-induced phospholipidosis: An analysis of its induction mechanism and establishment of a novel in vitro screening system. Sawada H, Takami K, Asahi S, Toxicol Sci 2005 83 282 292 15342952 (Pubitemid 40227898)
38. Gastric oxidative stress and hemorrhagic ulcer in Salmonella typhimurium-infected rats. Hung CR, Wang PS, Eur J Pharmacol 2004 491 61 68 10.1016/j.ejphar.2004.03.029 15102534 (Pubitemid 38501776)
39. Intestinal barrier function in response to abundant or depleted mucosal glutathione in Salmonella-infected rats. van Ampting MT, Schonewille AJ, Vink C, Brummer RJ, van der Meer R, Bovee-Oudenhoven IM, BMC Physiol 2009 9 6 19374741
40. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA, J Lipid Res 1982 23 1206 1223 7175378 (Pubitemid 13187618)
41. A simple method for the isolation and purification of total lipides from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 497 509 13428781
42. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Stewart JC, Anal Biochem 1980 104 10 14 10.1016/0003-2697(80) 90269-9 6892980 (Pubitemid 10045896)
43. The concept of precision extended to the atherogenic index of plasma. Holmes DT, Frohlich J, Buhr KA, Clin Biochem 2008 41 631 635 10.1016/j.clinbiochem.2008.01.023 18280809
44. Colorimetric microdetermination of free fatty acids. Soloni FG, Sardina LC, Clin Chem 1973 19 419 424 4704926
45. Colorimetric method for free fatty acids in serum validated by comparison with gas chromatography. Brunk SD, Swanson JR, Clin Chem 1981 27 924 926 7237775 (Pubitemid 11042778)
46. Improved procedure for the extraction of lipids from human erythrocytes. Rose HG, Oklander M, J Lipid Res 1965 6 428 431 14336214
47. The effect of zinc deficiency on erythrocyte membrane lipids of force-fed rats receiving a diet containing coconut oil or fish oil. Eder K, Kirchgessner M, J Trace Elem Electrolytes Health Dis 1994 8 63 73 7881279 (Pubitemid 24327629)
48. Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. Kriketos AD, Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV, J Clin Endocrinol Metab 2003 88 793 798 10.1210/jc.2002-020848 12574215 (Pubitemid 36207824)
49. The preparation of red cell ghosts (membranes). Hanahan DJ, Ekholm JE, Methods Enzymol 1974 31 168 172 4278921
50. Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue. Rao AV, Ramakrishnan S, Clin Chem 1975 21 1523 1525 1157326